Agreement On SPC Manufacturing Waiver Reached, Benefitting EU Generic, Biosimilar Industry14/02/2019 By David Branigan for Intellectual Property Watch Leave a CommentThe European Council reached a political agreement today on the SPC Manufacturing Waiver, which will allow the manufacture of generic and biosimilar medicines in the European Union for export and stockpiling during the period of extended patent protection provided for by the EU. This waiver will enable EU generic and biosimilar industries to benefit from sales outside the EU where patents have already expired, and to prepare to provide the EU market as soon as the extended period of patent protection ends.
South Africa’s Copyright Amendment Bill Still Moving14/02/2019 By Linda Daniels for Intellectual Property Watch Leave a CommentCopyright law stakeholders and pundits are keeping a close watch on the progress of South Africa’s Copyright Amendment Bill, as it makes its way to the National Council of Provinces in Parliament this week for further deliberation.
EU Copyright Rules: Provisional Deal Struck On Changes13/02/2019 By William New, Intellectual Property Watch 1 CommentThe European Council’s Romanian presidency announced today it has struck a provisional agreement with the EU Parliament on a draft directive that makes changes to existing European Union copyright rules. The draft agreement, which will go before the full Council of member states and Parliament for approval, would make changes such as a controversial new “publishers’ right,” and strengthens copyright protections on online content sharing platforms. It also would introduce copyright exceptions for a range of purposes such as text and data mining, online teaching, and cultural heritage.
Pre-Grant Opposition Filed Against Janssen’s Bedaquiline Fumarate Application In India08/02/2019 By Intellectual Property Watch 2 Comments
WHO’s Access Roadmap And The Art Of Accommodation Of Pharma Interest26/01/2019 By Intellectual Property Watch 1 Comment
US Complaints About Technology Transfer In China: Negotiating The Endgame24/01/2019 By Intellectual Property Watch 1 Comment
US IP Law – Big Developments On The Horizon In 201923/01/2019 By Steven Seidenberg for Intellectual Property Watch Leave a Comment
Special Report: Guide To This Week’s WHO Board Meeting – Budget, Medicines Access, Antimicrobial Resistance, NCDs, More18/01/2019 By Catherine Saez, Intellectual Property Watch 1 Comment
Malaysia Still Under Pressure To Make Hepatitis C Medicine More Expensive13/02/2019 By William New, Intellectual Property Watch Leave a Comment
WIPO Event: AI On All Fronts – Health, Cities, Agriculture – But Investment Needed; Europe Lagging12/02/2019 By Catherine Saez, Intellectual Property Watch 1 Comment
Women On The Rise In Patent Filings, But Still Underutilised Potential, USPTO Says12/02/2019 By David Branigan for Intellectual Property Watch Leave a Comment
TRIPS Council To Look At IP And The Public Interest, Business Interest11/02/2019 By William New, Intellectual Property Watch Leave a Comment
New High-Tech System Against Falsified Medicines Goes Live In Europe08/02/2019 By William New, Intellectual Property Watch Leave a Comment
The Future Of The Ideas Business – The Rise Of Data-Driven Invention07/12/2018 By Intellectual Property Watch, Intellectual Property Watch 1 CommentNew ideas are getting harder to find, and with less ideas there is a decline in organisational productivity and economic growth. This isn’t new, nor is the fact that to counterbalance the decline in idea generation, research and development have received and continue to require heavy investment. But with daily news of innovation centres opening up across the globe, the question remains whether initiatives like open innovation, crowdsourcing, or simply putting more scientific brains together will do this investment justice. Last month, leading representatives of the IP, R&D and technology arenas met in Switzerland to discuss a technology-based alternative to human only idea generation. Hosted by data-driven invention company Iprova, the 2nd Data-Driven Invention Forum saw attendees from companies, such as Panasonic, Philips and DuPont as well as many other global organisations explore the future of innovation and the role data-driven invention plays in it. Here are some of the conclusions of the conference.
